Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

被引:0
|
作者
Niels H. Brandt-Jacobsen
Marie Louise Johansen
Jon J. Rasmussen
Morten Dalsgaard
Thomas Kumler
Jens Faber
Patrick Rossignol
Morten Schou
Caroline Kistorp
机构
[1] Copenhagen University Hospital - Rigshospitalet,Department of Endocrinology
[2] University of Copenhagen,Department of Clinical Medicine, Faculty of Health and Medical Sciences
[3] Copenhagen University Hospital - Herlev and Gentofte Hospital,Department of Endocrinology
[4] Copenhagen University Hospital - Herlev and Gentofte Hospital,Internal Medicine
[5] Université de Lorraine,Department of Cardiology
[6] L’Institut National de la Santé et de la Recherche Médicale (URM-S 116),Department de Défaillance Cardiovasculaire Aiguë et Chronique
[7] Centre Hospitalier Régional Universitaire,Centre d’Investigation Clinique Plurithématique 1433
[8] French Clinical Research Infrastructure Network Investigation Network Initiative - Cardiovascular and Renal Clinical Trialists,undefined
[9] L’Institut National de la Santé et de la Recherche Médicale,undefined
关键词
Mineralocorticoid receptor antagonist; High-dose eplerenone; Global longitudinal strain; Systolic and diastolic function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
    Samaneh Kabul
    Robert C. Hood
    Ran Duan
    Amy M. DeLozier
    Julie Settles
    Health and Quality of Life Outcomes, 14
  • [42] Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
    Kabul, Samaneh
    Hood, Robert C.
    Duan, Ran
    DeLozier, Amy M.
    Settles, Julie
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [43] LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial
    Petrie, John R.
    Marso, Steven P.
    Bain, Stephen C.
    Franek, Edward
    Jacob, Stephan
    Masmiquel, Luis
    Leiter, Lawrence A.
    Haluzik, Martin
    Satman, Ilhan
    Omar, Mohamed
    Shestakova, Marina
    Van Gaal, Luc
    Mann, Johannes F.
    Baeres, Florian M. M.
    Zinman, Bernard
    Poulter, Neil R.
    JOURNAL OF HYPERTENSION, 2016, 34 (06) : 1140 - 1150
  • [44] Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection The COVID A to Z Randomized Clinical Trial
    Thomas, Suma
    Patel, Divyang
    Bittel, Barbara
    Wolski, Kathy
    Wang, Qiuqing
    Kumar, Anirudh
    Il'Giovine, Zachary J.
    Mehra, Reena
    McWilliams, Carla
    Nissen, Steve E.
    Desai, Milind Y.
    JAMA NETWORK OPEN, 2021, 4 (02)
  • [45] Effect of aprepitant on antiemetic protection in patients receiving moderately emetogenic chemotherapy plus high-dose cisplatin: Analysis of combined data from 2 phase III randomized clinical trials.
    Gralla, RJ
    Warr, DG
    Carides, AD
    Evans, JK
    Horgan, KJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 763S - 763S
  • [46] The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial
    Sivalingam, Suvanjaa
    Hein Zobel, Emilie
    Hansen, Christian S.
    Ripa, Rasmus S.
    von Scholten, Bernt J.
    Rotbain Curovic, Viktor
    Kjaer, Andreas
    Jensen, Jacob K.
    Hansen, Tine W.
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2022, 24 (08): : 1638 - 1642
  • [47] The effect of fenugreek seed supplementation on serum irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel randomized clinical trial
    Hadi, Amir
    Arab, Arman
    Hajianfar, Hossein
    Talaei, Behrouz
    Miraghajani, Maryam
    Babajafari, Siavash
    Marx, Wolfgang
    Tavakoly, Rahele
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49
  • [48] Glycemic Variability in Metformin/DPP-4 Inhibitor Compared with the High-Dose Metformin in Patients with Multiple-Daily-Insulin-Treated Type 2 Diabetes: A Prospective, Randomized, Controlled Trial
    Yoshikawa, Fukumi
    Uchino, Hiroshi
    Nagashima, Tomoko
    Kanazawa, Ken
    Shigiyama, Fumika
    Usui, Shuki
    Miyagi, Masahiko
    Kumashiro, Naoki
    Yoshino, Hiroshi
    Ando, Yasuyo
    Ikehara, Kayoko
    Hirose, Takahisa
    DIABETES, 2017, 66 : A235 - A235
  • [49] The effect of full-mouth tooth extraction on glycemic control among patients with type 2 diabetes requiring extraction of all remaining teeth: a randomized clinical trial
    Khader, Y. S.
    Al Habashneh, R.
    Al Malalheh, M.
    Bataineh, A.
    JOURNAL OF PERIODONTAL RESEARCH, 2010, 45 (06) : 741 - 747
  • [50] Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With Diabetes The FACTOR-64 Randomized Clinical Trial
    Muhlestein, Joseph B.
    Lappe, Donald L.
    Lima, Joao A. C.
    Rosen, Boaz D.
    May, Heidi T.
    Knight, Stacey
    Bluemke, David A.
    Towner, Steven R.
    Viet Le
    Bair, Tami L.
    Vavere, Andrea L.
    Anderson, Jeffrey L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (21): : 2234 - 2243